Donley Matthew Maxwell 4
4 · Aurinia Pharmaceuticals Inc. · Filed Mar 3, 2026
Insider Transaction Report
Form 4
Donley Matthew Maxwell
Chief Operating Officer
Transactions
- Award
Common Stock
[F1]2026-02-27+58,160→ 721,060 total - Tax Payment
Common Stock
[F2]2026-03-02$14.21/sh−40,761$579,214→ 680,299 total - Award
Employee Stock Option (right to buy)
[F3]2026-02-27+97,256→ 97,256 totalExercise: $13.97Exp: 2036-02-27→ Common Stock (97,256 underlying)
Footnotes (3)
- [F1]Each performance right represents a contingent right to receive one common share of the Issuer. The performance rights vest in four tranches upon the Issuer's common shares achieving four progressively higher target prices, with respective one year retention periods per tranche achievement.
- [F2]Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units.
- [F3]One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter.
Signature
/s/ Matthew Maxwell Donley|2026-03-03